//
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure